TABLE 1.
Prevalence of agr groups in different clinical settings
| agr group | No. (%) of isolates from:
|
Total | |||
|---|---|---|---|---|---|
| CF patients | Various infection sitesa | Multicenter studyb | Nasal carriage | ||
| I | 34 (44) | 29 (46) | 96 (44) | 41 (47) | 200 (45) |
| II | 22 (29) | 16 (24) | 63 (29) | 21 (24) | 122 (27) |
| III | 17 (22) | 12 (19) | 50 (23) | 25 (28) | 104 (23) |
| IV | 4 (5) | 7 (11) | 9 (4) | 1 (1) | 21 (5) |
| Total | 77 (100) | 64 (100) | 218 (100) | 88 (100) | 447 (100) |
a
Clinical isolates were recovered from patients with endocarditis (n = 7), osteomyelitis (n = 8), skin and soft tissue infections (impetigo, bursitis, staphylococcal scalded skin syndrome, finger pulp infection, cellulites, abscesses, and wound infection [n = 25]), device-related infection (n = 15), chronic otitis media (n = 7), pneumonia (n = 1), and cerebral nervous system infection (n = 1).
b
Bacteremic isolates.